Cited by 12

Raman and NIR Spectroscopy‐based Real‐Time Monitoring of the Membrane Filtration Process of a Recombinant Protein for the Diagnosis of SARS‐CoV‐2

Vaskó, Dorottya, Pantea, Eszter, Domján, Júlia, Fehér, Csaba, Mózner, Orsolya, Sarkadi, Balázs, Nagy, Zsombor K., Marosi, György J. +1 more·2024·International Journal of Pharmaceutics

Abstract

This research shows the detailed comparison of Raman and near-infrared (NIR) spectroscopy as Process Analytical Technology tools for the real-time monitoring of a protein purification process. A comprehensive investigation of the application and model development of Raman and NIR spectroscopy was carried out for the real-time monitoring of a process-related impurity, imidazole, during the tangential flow filtration of Receptor-Binding Domain (RBD) of the SARS-CoV-2 Spike protein. The fast development of Raman and NIR spectroscopy-based calibration models was achieved using offline calibration data, resulting in low calibration and cross-validation errors. Raman model had an RMSEC of 1.53 mM, and an RMSECV of 1.78 mM, and the NIR model had an RMSEC of 1.87 mM and an RMSECV of 2.97 mM. Furthermore, Raman models had good robustness when applied in an inline measurement system, but on the contrary NIR spectroscopy was sensitive to the changes in the measurement environment. By utilizing the developed models, inline Raman and NIR spectroscopy were successfully applied for the real-time monitoring of a process-related impurity during the membrane filtration of a recombinant protein. The results enhance the importance of implementing real-time monitoring approaches for the broader field of diagnostic and therapeutic protein purification and underscore its potential to revolutionize the rapid development of biological products.

Integrity signals

Registry

Crossref · 10.1016/j.ijpharm.2024.124251

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In-line monitoring of process impurities during recombinant protein purification was developed using calibration models based on Raman and NIR spectroscopy.

    “In Vasko et al. [69], an in‐line monitoring of process impurities during recombinant protein purification was developed using calibration models based on Raman and NIR spectroscopy.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Vaskó, D., Pantea, E., Domján, J., Fehér, C., Mózner, O., Sarkadi, B., Nagy, Z. K., Marosi, G. J., & Hirsch, E.
Venue
International Journal of Pharmaceutics
Publisher
Elsevier BV
Published
2024-07
Volume
660
Pages
124251
ISSN
0378-5173
Cited by
12
References
4
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review